Asensus Surgical Announces Installation of Senhance Surgical System in the Department of Gynecology at University Hospital Tübingen

RESEARCH TRIANGLE PARK, N.C., July 07, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSEAmerican:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the installation of a Senhance^® Surgical System in the Department of Gynecology at the University Hospital Tübingen. The Department of Gynecology at the University Hospital Tübingen previously initiated its Senhance Surgical program in December of 2021, as announced by the Company on January 10, 2022. The system will be initially utilized by the Department of Gynecology at the University Hospital Tübingen. Independent of the lease and utilization agreement, the Department of Gynecology at the University Hospital Tübingen has entered into a research agreement with the Company focused on collecting procedural and outcomes data for certain gynecologic procedures performed with the Senhance system.